OWINGS MILLS, Md., June 30 /PRNewswire-FirstCall/ -- Medifast, Inc. (NYSE: MED) today announced that the company was added to the broad-market Russell 3000(R) Index effective at the close of market on June 26, 2009, when Russell Investments reconstituted its comprehensive set of U.S. and global equity indexes. Russell Investments adjusts its indexes annually in order to accurately rank the 3,000 largest companies in the U.S. stock market by market capitalization.
Mr. Michael S. McDevitt, Chief Executive Officer of Medifast, Inc. commented, "We are pleased to be included in the Russell Indexes. It is an acknowledgment of the execution of our business plan over the past year, and the value that has been created for our loyal shareholders."
Medifast (NYSE: MED) is the leading easy-to-use, clinically proven portion-controlled weight loss program. Medifast has been recommended by 15,000 physicians and used by over one million customers. Medifast is committed to enriching lives by providing innovative choices for lasting health. Medifast programs have been proven effective through studies by major university teaching hospitals. The company sells its products and programs via four unique distribution channels: 1) the web and national call centers, 2) national network of physicians, 3) medically supervised Medifast Weight Control Centers, and 4) the Take Shape For Life direct-selling division, a network of health coaches. Medifast was founded in 1980 and is located in Owings Mills, Maryland. For more information, log onto http://www.ChooseMedifast.com. MED-F
Please Note: This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally can be identified by use of phrases or terminology such as "intend" or other similar words or the negative of such terminology. Similarly, descriptions of Medifast's objectives, strategies, plans, goals or targets contained herein are also considered forward-looking statements. Medifast believes this release should be read in conjunction with all of its filings with the United States Securities and Exchange Commission and cautions its readers that these forward-looking statements are subject to certain events, risks, uncertainties, and other factors. Some of these factors include, among others, Medifast's inability to attract and retain independent Associates and Members, stability in the pricing of print, TV and Direct Mail marketing initiatives affecting the cost to acquire customers, increases in competition, litigation, regulatory changes, and its planned growth into new domestic and international markets and new channels of distribution. Although Medifast's believes that the expectations, statements, and assumptions reflected in these forward-looking statements are reasonable, it cautions readers to always consider all of the risk factors and any other cautionary statements carefully in evaluating each forward-looking statement in this release, as well as those set forth in its latest Annual Report on Form 10-K and Quarterly Report on Form 10-Q, and other filings filed with the United States Securities and Exchange Commission, including its current reports on Form 8-K. All of the forward-looking statements contained herein speak only as of the date of this release.
Contact: Brendan Connors Lytham Partners, LLC Vice President - Finance Joe Diaz firstname.lastname@example.org Robert Blum Joe Dorame 602-889-9700
|SOURCE Medifast, Inc.|
Copyright©2009 PR Newswire.
All rights reserved